ERBB2 and neoplasm: A significant difference among the three groups was detected for Ki-67 index, with 66.3% exhibiting Ki-67 expression > 20% in HER2-low tumor, compared with 80.3% in HER2-zero and 81.7% in HER2-positive tumors (p = 0.028; Table 2).